Physician profile
Eric Elias
NPI 1043447196
$1,244.05
in general payments reported to CMS, 2019-2025
14 companies · $631 in 2025
The $631 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.77 · 2020: $32.13 · 2021: $11.14 · 2022: $97.22 · 2023: $227 · 2024: $211 · 2025: $631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $870 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $869.80 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $233.92 | 2023-2025 | Veozah |
| Evofem Biosciences, INC. | $217.87 | 2022-2025 | Phexxi, Solosec, Phexx |
| Exeltis, USA INC. | $194.48 | 2021-2025 | Slynd |
| Mayne Pharma Commercial LLC | $98.84 | 2025 | |
| Millicent US INC | $83.27 | 2024-2025 | Femlyv, Intrarosa, Femring |
| Ethicon US, LLC | $83.00 | 2022-2025 | Vistaseal, Stratafix |
| Pfizer INC. | $82.53 | 2022-2024 | |
| Abbvie INC. | $58.26 | 2022-2023 | |
| Mckesson Medical-Surgical, INC. | $37.76 | 2025 | |
| Hologic Sales and Service, LLC | $34.77 | 2019 | |
| Organon LLC | $32.15 | 2022-2024 | |
| Coopersurgical, INC. | $32.13 | 2020 | |
| Becton, Dickinson and Company | $30.17 | 2024-2025 | Bd Max System, Bd Max Instrument |
| Bayer Healthcare Pharmaceuticals INC. | $24.90 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Elias listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.